Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer

Around 8–12% of patients with advanced colon rectal cancer (CRC) present with BRAF alterations, in particular V600E mutation, which is associated with right-side, poorly differentiated and mucinous type tumors. The presence of BRAF mutation (BRAF-mt) has been identified as a hallmark of poor prognos...

Descripción completa

Detalles Bibliográficos
Autores principales: Grassi, Elisa, Corbelli, Jody, Papiani, Giorgio, Barbera, Maria Aurelia, Gazzaneo, Federica, Tamberi, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262685/
https://www.ncbi.nlm.nih.gov/pubmed/34249672
http://dx.doi.org/10.3389/fonc.2021.601722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262685/
https://www.ncbi.nlm.nih.gov/pubmed/34249672
http://dx.doi.org/10.3389/fonc.2021.601722

Ejemplares similares